NIT1
Showing 1 - 25 of 53
Heart Failure, Iron-deficiency, Heart Failure, Systolic Trial (Sucrosomial iron, Vitamin D, Ferric Carboxymaltose 50 MG/ML)
Not yet recruiting
- Heart Failure
- +5 more
- Sucrosomial iron
- +2 more
- (no location specified)
Jan 18, 2023
Inherited Metabolic Disorder of Nervous System, Schizophrenia Trial in Grenoble (Sulfitest)
Recruiting
- Inherited Metabolic Disorder of Nervous System
- Schizophrenia
- Sulfitest
-
Grenoble, FranceCHU Grenoble Alpes
May 6, 2022
Nit-Occlud PDA Post-Approval Study
Completed
- Patent Ductus Arteriosus (PDA)
- PDA Coil
-
Loma Linda, California
- +10 more
Sep 30, 2022
Pain, Postoperative Trial in Jena (Prospective data collection)
Completed
- Pain, Postoperative
- Prospective data collection
-
Jena, Thuringia, GermanyJena University Hospital
Nov 1, 2022
Urinary Tract Infections Trial in Doorn, Utrecht (Fosfomycin, Nitrofurantoin)
Terminated
- Urinary Tract Infections
-
Doorn, Utrecht, Netherlands
- +3 more
Feb 27, 2022
Type2 Diabetes Trial in Clichy (new quantitative imaging techniques with contast products, blood sample, second generation
Recruiting
- Type2 Diabetes
- new quantitative imaging techniques with contast products
- +2 more
-
Clichy, FranceHôpital Beaujon
Mar 21, 2022
Angina, Stable Trial in Denmark, Sweden (CADScor®System)
Recruiting
- Angina, Stable
- CADScor®System
-
Copenhagen S, Denmark
- +5 more
Mar 1, 2022
French Observatory of Congenital Ventricular Septal Defect With
Active, not recruiting
- Congenital Heart Disease
-
Le Plessis Robinson, France
- +3 more
Sep 20, 2022
Any Advanced Solid Tumors, Triple Negative Breast Cancer, Non Small Cell Lung Cancer Trial in United States (NT-I7,
Recruiting
- Any Advanced Solid Tumors
- +6 more
-
Tampa, Florida
- +7 more
Jul 13, 2022
Citrulline, Nitrate, Athletes Trial in León (Citrulline, Nitrate, Nitrate plus Citrulline)
Completed
- Citrulline
- +2 more
- Citrulline
- +3 more
-
León, Castilla Y León, SpainUniversity of Leon
Nov 21, 2021
NSCLC, NSCLC, Non-Small Cell Lung Carcinoma Trial in United States (efineptakin alfa, Atezolizumab)
Recruiting
- Carcinoma, Non-Small-Cell Lung
- +4 more
- efineptakin alfa
- Atezolizumab
-
Mobile, Alabama
- +14 more
May 12, 2022
Coronary Artery Disease, Angina Pectoris, Myocardial Infarction Trial in Aarhus, Odense (Everolimus eluting bioresorbable
Active, not recruiting
- Coronary Artery Disease
- +2 more
- Everolimus eluting bioresorbable polymer stent
- Biolimus eluting bioresorbable polymer stent
-
Aarhus, Denmark
- +1 more
Oct 17, 2022
Esophageal Squamous Cell Carcinoma Trial in Shanghai (Nivolumab, Cisplatin, Paclitaxel)
Recruiting
- Esophageal Squamous Cell Carcinoma
- Nivolumab
- +4 more
-
Shanghai, China180 Fenglin Road
Jun 12, 2022
Pandemic on the Health Personnel Working in the Filiation Team
Not yet recruiting
- Health Personnel
- The Psychological Effects of The Covid-19 Pandemic Process
- (no location specified)
Feb 3, 2022
Healthy Volunteers Trial in Zhuhai (TNM002, Placebo)
Completed
- Healthy Volunteers
- TNM002
- Placebo
-
Zhuhai, Guangdong, ChinaThe Fifth Affiliated Hospital Sun Yat-sen University
Apr 24, 2023
Non-muscle Invasive Bladder Cancer Trial in Shanghai (APL-1202 in combination with Epirubicin, Placebo in combination with
Active, not recruiting
- Non-muscle Invasive Bladder Cancer
- APL-1202 in combination with Epirubicin
- Placebo in combination with Epirubicin
-
Shanghai, Shanghai, ChinaFudan University Shanghai Cancer Center
Feb 21, 2022
Fatty Liver, Nonalcoholic, Diabetes, Type 2 Trial in Hong Kong (Simple fibrosis scores and electronic reminder messages)
Active, not recruiting
- Fatty Liver, Nonalcoholic
- Diabetes Mellitus, Type 2
- Simple fibrosis scores and electronic reminder messages
-
Hong Kong, Hong KongPrince of Wales Hospital
Jul 22, 2022
Intracanal Medication Trial (Nitrofurantoin capsules)
Not yet recruiting
- Intracanal Medication
- Nitrofurantoin capsules
- (no location specified)
Oct 2, 2021
Non-muscle Invasive Bladder Cancer Trial in Shanghai (APL-1202, Epirubicin Hydrochloride)
Recruiting
- Non-muscle Invasive Bladder Cancer
- APL-1202
- Epirubicin Hydrochloride
-
Shanghai, Shanghai, ChinaFudan University Shanghai Cancer Center
Feb 21, 2022
Cardiovascular Diseases Trial in London (Beetroot Juice)
Active, not recruiting
- Cardiovascular Diseases
- Beetroot Juice
-
London, United KingdomWilliam Harvey Research Institute, Barts and The London School o
Sep 14, 2022
Refractory Diffuse Large B-cell Lymphoma, Refractory DLBCL, Not Otherwise Specified, Recurrent DLBCL Trial in Duarte, Saint
Recruiting
- Refractory Diffuse Large B-cell Lymphoma
- +4 more
-
Duarte, California
- +2 more
Aug 9, 2022
Healthy Adult Subjects Trial in Sydney (TNM002 Dosage 1 (10 µg/kg), Placebo, TNM002 Dosage 2 (35 µg/kg))
Completed
- Healthy Adult Subjects
- TNM002 Dosage 1 (10 μg/kg)
- +4 more
-
Sydney, New South Wales, AustraliaScientia Clinical Research
Nov 2, 2022
Substance Abuse Trial in Salt Lake City (Strengthening Families Program Online eLearning Game, SFP Home-use DVD, Wait-Listed
Active, not recruiting
- Substance Abuse
- Strengthening Families Program Online eLearning Game
- +2 more
-
Salt Lake City, UtahStrengthening Families Program LLC
Jan 5, 2023